.
BUDGET 2012
 | News | Market | Portfolio | Messages
SENSEX
25229.70 -207.27 (-0.81%)
NIFTY 50
7747.00 -58.90 (-0.75%)
Go to Moneycontrol Home
Pharmaceuticals
Ajanta Pharma Q4 profit up 43% but operating margin disappoints
"We have significantly increased R&D spend during the year to capitalise on the identified opportunities. For Q4, R&D sp
Sanofi India posts 25% rise in Q1 net profit
Glenmark gets USFDA tentative nod for acne gel
Lupin firms up US brand portfolio with generic Methergine tabs
Granules' board approves Rs 167 cr investment proposal
Thyrocare IPO fully subscribed
Torrent recalls 20,952 cartons of hypertension drug in US
STOCK RECOMMENDATION
Stock Advice
Buy Aurobindo Pharma, Rolta India, Bharti Airtel: Ashwani Gujral
Buy Ajanta Pharma, DLF, Canara Bank: Ashwani Gujral
Buy SPARC, Idea Cellular; sell UPL: Ashwani Gujral
more
Broker Reports
Buy Sun Pharma; target of Rs 920: Edelweiss
Buy Torrent Pharma; target of Rs 1840: Edelweiss
Buy Aurobindo Pharma;target of Rs 940: Axis Securities
more
Budget 2012
HOME
Font Size: S M L
Mobile | Classic
Customer Support
© 2011. a Web18 Venture